This statistic shows the availability of new cancer drugs that were launched in 2013-2017, as of December 2018, by country. At this time, ** out of 54 new cancer drugs were available in the United States. Thus, the U.S. had the highest availability rate among all countries.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
IQVIA. (May 28, 2019). Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 03, 2026, from /statistics/696020/availability-of-new-oncology-drugs-by-country/
IQVIA. "Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018." Chart. May 28, 2019. ÌÇÐÄÆƽâ°æ. Accessed August 03, 2026. /statistics/696020/availability-of-new-oncology-drugs-by-country/
IQVIA. (2019). Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 03, 2026. /statistics/696020/availability-of-new-oncology-drugs-by-country/
IQVIA. "Availability of New Cancer Drugs Launched in 2013-2017 in Selected Countries as of 2018." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 May 2019, /statistics/696020/availability-of-new-oncology-drugs-by-country/
IQVIA, Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018 ÌÇÐÄÆƽâ°æ, /statistics/696020/availability-of-new-oncology-drugs-by-country/ (last visited August 03, 2026)
Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018 [Graph], IQVIA, May 28, 2019. [Online]. Available: /statistics/696020/availability-of-new-oncology-drugs-by-country/
